|
|
|
|
|||||
|
|
|
Biodesix Inc. (NASDAQ:BDSX) is one of the best penny stocks under $1 to buy now. On June 10, Biodesix announced a new partnership with the Association of Pulmonary Advanced Practice Providers/APAPP. The collaboration aims to deliver the nation’s first CME-accredited medical education program for Advanced Practice Providers/APPs, focusing on the clinical application of diagnostic biomarkers in lung nodule and lung cancer programs.
The partnership will introduce new educational resources for Lung Health providers, specifically on innovative lung nodule risk assessment testing, such as the Nodify Lung blood-based tests, and cancer treatment decision support testing, such as the IQLun blood-based tests.
According to the American Lung Association, lung cancer remains the deadliest of all cancers, claiming nearly as many American lives annually as breast, prostate, and colon cancers combined.
Biodesix Inc. (NASDAQ:BDSX) is a diagnostic solutions company that offers blood-based lung tests to assess the risk of lung cancer and identify the appropriate treatment pathway.
While we acknowledge the potential of BDSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
| Jul-25 | |
| Jul-25 | |
| Jul-24 | |
| Jun-10 | |
| May-22 | |
| May-21 | |
| May-15 | |
| May-14 | |
| May-14 | |
| May-13 | |
| May-13 | |
| May-12 | |
| May-12 | |
| May-08 | |
| Apr-30 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite